“SAMe 2.0” going beyond mood health and defining its new role in brain health

31-Mar-2022

According to NBJ, the Mood & Brain Health is expected to forecast robust growth in the upcoming two years. Among the central ingredients, SAMe holds its leader position to sustain a healthy mood while a new trend in the US is arising. SAMe is introduced in brand-new formulations as a wonderful dynamic duo, working in synergy with another powerful ingredient – choline - to promote optimal brain health and functioning

In the current challenging scenario of our society, where postpandemics meets geopolitical instability, consumers are striving hard and actively looking for solutions to recover their mood balance and mental strength. According to NBJ, the Mood & Brain Health is expected to forecast robust growth in the upcoming two years. Among the central ingredients on the market, SAMe holds its leader position to sustain a healthy mood while a new trend in the US is arising.

SAMe is a naturally occurring compound in every cell of the human body and it plays a central role in the methylation process, ensuring the maintenance of the normal cellular metabolism and functioning. This important metabolite has shown during the last 30 years in many preclinical and clinical applications its primary role in supporting a healthy Mood and is now gaining more and more space in the Brain Health category.

Historically difficult to formulate in combination with other active ingredients for its intrinsic instability, SAMe is introduced today in brand-new formulations as a wonderful dynamic duo, working in synergy with another powerful ingredient – the choline - to promote optimal brain health and functioning.

The new combo answers the marketing need to explore new associations to tackle Brain Health, combining state-of-the-art industrial manufacturing, relentless innovation, and esteemed research, based on the branded Adonat® Premium SAMe of Gnosis by Lesaffre.

Sign up for your free email newsletter

Featured Companies